Finding the Optimal Dose: What Strength of Wegovy Works Best for You?

Last reviewed: June 17, 2026

Last updated: June 17, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide has helped millions manage weight by slowing stomach emptying and reducing appetite signals to the brain. However, the right dose varies significantly between individuals—some reach their goal weight at 0.5 mg weekly, while others benefit from higher strengths. PlexusDx personalizes semaglutide selection and dose progression based on your unique genetic and metabolic profile.

How Semaglutide Doses Work for Weight Loss

Semaglutide belongs to a class of medications called GLP-1 receptor agonists that mimic a natural hormone controlling hunger and blood sugar. Treatment typically begins at a lower dose and increases gradually over weeks or months—a process called titration. This stepwise approach allows your body to adjust and helps identify the minimum effective dose that works for your metabolism.

Clinical trials show that most patients see meaningful weight loss results at doses between 1.0 and 2.4 mg weekly, though individual responses vary widely. Some people experience significant appetite reduction at lower doses, while others require higher strengths to achieve their target weight. The goal isn't to reach the maximum dose—it's to find the strength that produces the best results with manageable side effects for your body.

Factors That Determine Your Optimal Semaglutide Strength

Your starting weight, age, metabolic rate, and previous weight loss attempts all influence how your body responds to semaglutide. Someone who has struggled with yo-yo dieting may need a different approach than someone managing weight for the first time. Additionally, certain medications you take for blood pressure, diabetes, or other conditions can interact with semaglutide, affecting the ideal dose for your situation.

The PlexusDx Precision Peptide Genetic Test analyzes GIPR — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

What to Expect During Semaglutide Dose Escalation

Most semaglutide protocols start at 0.25 mg weekly for four weeks, then increase by 0.25 mg increments every four weeks until reaching your target dose or achieving your weight loss goals. This gradual escalation minimizes nausea and other gastrointestinal side effects while giving your metabolism time to adapt. Your provider monitors your progress and side effects at each step to decide whether to continue increasing or maintain your current dose.

Some patients feel satisfied with appetite control and weight loss at intermediate doses like 1.0 or 1.5 mg weekly and choose not to escalate further. This is entirely appropriate—your optimal dose is the one that delivers results you're happy with, not the highest dose available. PlexusDx compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan flat, meaning your dose can increase without increasing your cost.

Using Genetic Testing to Personalize Your Semaglutide Plan

The PlexusDx Precision Peptide Genetic Test analyzes GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to Wegovy or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Armed with your genetic insights, PlexusDx providers can recommend whether to start semaglutide, consider a dual-compound approach like GLP-Squared, or explore alternative treatments based on your unique peptide pathway profile. Genetic testing is available for $298, giving you and your provider data-driven guidance for optimizing your long-term weight loss strategy.

Common Semaglutide Dosing Questions Answered

Many patients wonder whether compounded semaglutide works the same as brand-name Wegovy or Ozempic—the answer is yes, when sourced from licensed 503A compounding pharmacies like those used by PlexusDx. The active pharmaceutical ingredient is identical; the difference is cost and convenience. PlexusDx serves all 50 states without insurance requirements or membership fees, making semaglutide accessible regardless of coverage status.

If you've tried semaglutide elsewhere and didn't see results at standard doses, PlexusDx's genetic testing can reveal whether a different medication class (like tirzepatide) or a dual-compound option might suit your metabolism better. Your dose may need to go up, or your medication may need to change—but your monthly price remains flat across commitment tiers, eliminating the financial barrier to finding what truly works.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

What is the typical starting dose of semaglutide for weight loss?

Most semaglutide protocols begin at 0.25 mg injected once weekly for the first four weeks, then increase by 0.25 mg increments every four weeks as tolerated. Your provider may adjust this timeline based on your metabolic profile, existing medications, and how you respond to each dose level.

Can my semaglutide dose be too high?

Yes—doses higher than your body needs increase the risk of side effects like severe nausea, vomiting, or pancreatitis without improving weight loss results. The goal is finding your minimum effective dose, not the maximum. If you experience intolerable side effects, your provider can reduce your dose or switch you to a different medication.

How long does it take to reach my target semaglutide dose?

No — the Precision Peptide Genetic Test does not predict your response to Wegovy or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Will my semaglutide cost increase if I increase my dose?

No. PlexusDx compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan flat across all three commitment tiers. Your dose may increase over time, but your monthly price remains the same—eliminating the financial burden of finding your optimal strength.

How does the Precision Peptide Genetic Test help with semaglutide dosing?

The test maps your genetic variants in GIPR, FTO, and MC4R, and 10 other appetite-control pathways, predicting how sensitively your body responds to semaglutide at different doses. This allows your PlexusDx provider to recommend a personalized starting dose and escalation plan, rather than using a one-size-fits-all approach. The test is $298.

What if semaglutide doesn't work at any dose for me?

PlexusDx offers alternative medications including tirzepatide (a dual GIP/GLP-1 agonist that works differently) and GLP-Squared, a dual-compound injection combining semaglutide and tirzepatide. If your genetic test shows poor predicted response to GLP-1 alone, your provider can recommend switching medications before wasting time on ineffective dosing.

Related Reading

• Wegovy Strength
• Ro Wegovy
• Mochi Wegovy
• Noom Wegovy

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.